Sort
21,453 grants matching “tuberculosis”
Cost-effective chronic disease prevention in developing countries
$127,386Jeremy David Goldhaber-Fiebert · Stanford University · K01 · FY2011 · AG
Cost-effective chronic disease prevention in developing countries
$127,386Jeremy David Goldhaber-Fiebert · Stanford University · K01 · FY2012 · AG
Cost-effective chronic disease prevention in developing countries
$127,386Jeremy David Goldhaber-Fiebert · Stanford University · K01 · FY2014 · AG
Cost-effective chronic disease prevention in developing countries
$127,386Jeremy David Goldhaber-Fiebert · Stanford University · K01 · FY2015 · AG
TUBERCULOSIS ELIMINATION AND LABORATORY
$127,376Justina R Langidrik · Republic Of The Marshall Iss Dept/Hlth S · U52 · FY2007 · PS
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$127,375Justina R Langidrik · Republic Of The Marshall Iss Dept/Hlth S · U52 · FY2008 · PS
Identifying effective and efficient approaches to tuberculosis screening in Brazilianprisons
$127,278Leonardo Martinez · Boston University Medical Campus · K01 · FY2024 · AI
ROLE &MECHANISM OF APOPTOSIS IN THE HOST RESPONCE TO TB
$127,278Boston University Medical Campus · K08 · FY2000 · HL
Identifying effective and efficient approaches to tuberculosis screening in Brazilianprisons
$127,278Leonardo Martinez · Boston University Medical Campus · K01 · FY2025 · AI
Tuberculosis in teens: a geospatial approach to predict community transmission
$127,278Meredith Blair Brooks · Harvard Medical School · K01 · FY2021 · AI
Pharmacology and Pharmacometrics Core
$127,276Eric L Nuermberger · Johns Hopkins University · P30 · FY2023 · AI
Ident/Characterization of M.tuberculosis Late Genes
$127,224Niaz Banaiee · New York University School Of Medicine · K08 · FY2006 · AI
Ident/Characterization of M.tuberculosis Late Genes
$127,224New York University School Of Medicine · K08 · FY2005 · AI
Ident/Characterization of M.tuberculosis Late Genes
$127,224Niaz Banaiee · Stanford University · K08 · FY2007 · AI
Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents
$127,215Erick Strauss · Stellenbosch University · R01 · FY2022 · AI
Structure and Function of Response Regulator Proteins
$127,204Ann M. Stock · Univ Of Med/Dent Nj-R W Johnson Med Sch · R37 · FY2009 · GM
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
$127,198Judith S. Currier · University Of California Los Angeles · UM1 · FY2025 · AI
Vaccine and Treatment Evaluation Units
$127,192Nadine Georges Rouphael · Emory University · UM1 · FY2022 · AI
Basic Science Core - Animal models
$126,967Shannan Hall-Ursone · Texas Biomedical Research Institute · P30 · FY2025 · AI
Concurrent HAART and Tuberculosis Treatment: Drug to Drug Interactions
$126,954Awewura Jacob Kwara · Miriam Hospital · K23 · FY2007 · AI
Concurrent HAART and Tuberculosis Treatment: Drug to Drug Interactions
$126,954Awewura Jacob Kwara · Miriam Hospital · K23 · FY2010 · AI
Concurrent HAART and Tuberculosis Treatment: Drug to Drug Interactions
$126,954Awewura Jacob Kwara · Miriam Hospital · K23 · FY2009 · AI
Concurrent HAART and Tuberculosis Treatment: Drug to Drug Interactions
$126,954Awewura Jacob Kwara · Miriam Hospital · K23 · FY2008 · AI
Concurrent HAART and Tuberculosis Treatment: Drug to Drug Interactions
$126,954Awewura Jacob Kwara · Miriam Hospital · K23 · FY2006 · AI
STRUCTURE/FUNCTION RELATIONSHIP FOR ANTIBODIES TO M. TUB
$126,900Yeshiva University · K08 · FY2003 · AI